You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD4 Lymphenia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Circulating Cluster of Differentiation 4 Positive 28 Null T

Not yet recruiting
  • Autoimmune Hemolytic Anemia
    • (no location specified)
    Jan 31, 2023

    Chronic Myelomonocytic Leukemia Trial in Indianapolis (CD4CAR)

    Not yet recruiting
    • Chronic Myelomonocytic Leukemia
    • CD4CAR
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Oct 2, 2023

    T-cell Lymphoma, T-cell Leukemia Trial in Indianapolis (CD4CAR)

    Recruiting
    • T-cell Lymphoma
    • T-cell Leukemia
    • CD4CAR
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Dec 16, 2022

    Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction

    Not yet recruiting
    • Hiv
    • +5 more
    • differences in CD4 reconstruction
    • (no location specified)
    Sep 17, 2023

    Idiopathic CD4 Lymphopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Recombinant human

    Not yet recruiting
    • Idiopathic CD4 Lymphopenia
    • Recombinant human interleukin (IL) 7-hyFc
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +4 more
    • (no location specified)
    Oct 23, 2023

    CD4/CD8+ Interferon Gamma Release Assay for Monitoring

    Active, not recruiting
    • Tuberculosis
    • Interferon gamma release assay (IGRA)
    • Milano, Italy
      IRCCS San Raffaele Scientific Institute
    Feb 13, 2023

    Health Status of Children Born After Assisted Reproductive

    Recruiting
    • Children Born After Assisted Reproductive Technologies
    • +2 more
    • hemogram examination
    • Almaty, Kazakhstan
      Sevara ilmuratova
    Oct 17, 2023

    Hiv Trial in Philadelphia (Autologous CD4 T-Cells)

    Completed
    Has Results
    • Hiv
    • Autologous CD4 T-Cells
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Nov 13, 2022

    Psoriasis Trial in Sohag (skin biopsy)

    Not yet recruiting
    • Psoriasis
    • skin biopsy
    • Sohag, Egypt
      Sohag university Hospital
    Sep 21, 2023

    Natural History of Idiopathic CD4+ Lymphocytopenia

    Recruiting
    • Idiopathic CD4+ Lymphocytopenia
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 18, 2022

      Idiopathic CD4-Positive, T-Lymphocytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

      Recruiting
      • Idiopathic CD4-Positive
      • T-Lymphocytopenia
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 21, 2023

      Hodgkin Lymphoma, Relapse, Refractory Trial in Chapel Hill (Chemotherapy, Cell infusion)

      Not yet recruiting
      • Hodgkin Lymphoma
      • +2 more
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center
      Oct 13, 2023

      Idiopathic CD4 T Cell Lymphocytopenia Trial run by the NIAID (Gardasil 9)

      Recruiting
      • Idiopathic CD4 T Cell Lymphocytopenia
      • Gardasil 9
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 10, 2023

      Optimising Cohorts for HIV Cure Interventions

      Recruiting
      • HIV-1-infection
      • no intervention
      • Prahran, Victoria, Australia
        Alfred Health
      May 1, 2023

      HIV-1-infection Trial (FMT capsules, Placebo capsules)

      Not yet recruiting
      • HIV-1-infection
      • FMT capsules
      • Placebo capsules
      • (no location specified)
      Aug 31, 2023

      CD4+T Lymphocytes in Primary Nephrotic Syndrome With Infection

      Recruiting
      • Nephrotic Syndrome
      • +2 more
      • The study is an observational study without intervention
      • Zhuhai, Guangdong, China
        the fifth affiliated hospital of SUN YAT-SEN university
      Nov 20, 2022

      T-cell Lymphoma Trial (CHOP + CD4, CHOP)

      Terminated
      Has Results
      • T-cell Lymphoma
      • (no location specified)
      May 2, 2022

      Immune Markers in Pediatric ITP

      Not yet recruiting
      • ITP - Immune Thrombocytopenia
      • complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
      • (no location specified)
      Oct 17, 2023

      Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

      Suspended
      • Juvenile Myelomonocytic Leukemia
      • +27 more
      • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
      • +2 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 11, 2023

      Aviremic HIV-1 in CD4+ T Cells of Adults Undergoing Treatment

      Recruiting
      • HIV-1-infection
      • Bioclinical evaluation
      • Nîmes, France
        CHU de Nimes
      Jul 28, 2022

      Ovarian Cancer Trial (Autologous genetically modified ADP-A2M4CD8 cells, Autologous genetically modified ADP-A2M4CD8 cells in

      Not yet recruiting
      • Ovarian Cancer
      • Autologous genetically modified ADP-A2M4CD8 cells
      • Autologous genetically modified ADP-A2M4CD8 cells in combination with Nivolumab
      • (no location specified)
      Jan 31, 2023

      HIV-1 Infections Trial in Washington (HAART, T cells)

      Completed
      • HIV-1 Infections
      • Washington, District of Columbia
        Walter Reed Army Medical Center
      Aug 17, 2022

      T Cell Lymphoma, T-cell Leukemia Trial in Beijing (Efficacy of LCAR-T2C CAR-T cells)

      Terminated
      • T Cell Lymphoma
      • T-cell Leukemia
      • Efficacy of LCAR-T2C CAR-T cells
      • Beijing, Beijing, China
      • +1 more
      Aug 12, 2022

      Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases

      Not yet recruiting
      • Multi-Drug Resistant Hiv-1 Infection
      • HIV-1 Infection
      • UB-421
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023